Objective: Aim of the study was to evaluate the cumulative success of colectomy and ileorectal anastomosis in 20 patients with ulcerative colitis. Patients and Methods: Data were collected from patient histories and cumulative success was calculated by the Kaplan-Meier method. Results: Seven of 20 (35 %) ileorectal anastomoses were lost. Cumulative success rate was 84 % at 5 years, 69 % at 10 years and 56 % at 20 years. Most common indication for proctectomy was disabling proctitis. Other reasons for failure were postoperative ileal necrosis and persisting presacral infection. Patients with advanced colonic cancer managed relatively well with ileorectal anastomosis until death. No cases of rectal cancer were detected during postoperative follow-up but one moderate dysplasia was treated locally. Conclusion: Ileorectal anastomosis can be chosen for patients who are not suitable for ileoanal operation. Rectal endoscopies are mandatory postoperatively.
INTRODUCTION
The aim of operative therapy for ulcerative colitis (UC) has always been to to ameliorate gastrointestinal symptoms of UC and to abolish the colorectal cancer risk associated with the disease. Widely accepted operative methods include proctocolectomy and Brooke's ileostomy, Kock's continent ileostomy and proctocolectomy and ileoanal anastomosis (IPAA), which is currently the standard method of choice for UC. Colectomy and ileorectal anastomosis (IRA) has been considered as an unorthodoxic method for UC for several reasons. The cancer risk persists in the rectal stump after the operation and inflammation continues in rectal mucosa, resulting in difficult diarrhea (1-3). However, some centers still favour IRA as a primary procedure for UC, be-cause of easier technique and the later possibility to continue either with proctectomy or IPAA (4). At our department, Kock's continent ileostomy was adopted in 1972 and IAA in 1985 (5-7). In all, we have been satisfied with the results of IPAA and colectomy and IRA has seldom been chosen and only for special reasons. Now we evaluated how these patients have managed with the ileorectal anastomosis.
PATIENTS AND METHODS
Data were retrospectively collected from the patient histories (Table1). Follow-up varied from 3.7 to 25.2 years (mean 18.0). Between the years 1978-2000, colectomy and ileorec- tal anastomosis was undertaken for twenty patients with the diagnosis of UC. The total number of proctocolectomies in the same time period was about 620 (491 with ileoanal pouch procedure, 129 with a permanent ileostomy). Ileorectal anastomoses were hand-sewn and made to the upper third of rectum. Twelve of operations were done before the IPAA era (1985) . Ten of the patients were women and ten were men. Age range at the time of operation was 22 to 66 (median 47, mean 43) years. Eight patients were known to have colitis carcinoma before the operation and one had severe dysplasia in caecal mucosa. Of the patients with carcinoma, one had Dukes B carcinoma, one had two Dukes A and one Dukes B carcinomas, one had Dukes A carcinoma, two had Dukes C carcinoma and three had Dukes D carcinoma with peritoneal metastases. None had had active inflammation or dysplastic changes in the rectum preoperatively. All procedures, which were made to patients under 40 years (8 patients), were before the year 1985. In these patients, the avoidance of ileostomy was one of the indications for ileorectal anastomosis. After year 1990, ileorectal anastomosis, instead of IAA, was chosen for three patients because of patients' general health and own preference. These patients were 63, 65 and 66 years old. In three cases, the operative findings (peritoneal metastases) affected the choice of the procedure. The study was approved by local ethics committee.
STATISTICAL METHODS
The cumulative probability of the success of the ileorectal anastomosis was estimated by Kaplan-Meier survivorship method (SPSS/PC+, SPSS Inc., Chicago, IL).
RESULTS
Six patients had died at the time of analysis. Deaths were not related to the operations. Two died for cardiac reasons and four for the spreading of colon carcinoma. Dukes C carcinoma of one female patient later progressed and she died three years after the operation. One of the three patients with peritoneal metastasis at primary operation lived six years with IRA. The other two had aggressive progression of the malignancy and they died after two months of the primary operation. Nine patients had proctitis. Of these, four patients had 5-aminosalisylic acid (Pentasa, Asacol) therapy per rectum and four patients had a reoperation because of disabling proctitis. Of these four three had proctectomy and ileorectostomy converted to conventional Brooke's ileostomy after 6, 11 and 23 years after the primary operation and one had her IRA converted to IAA after 8 years of the primary operation. One patient had a persisting sinus tract from the anastomosis to the presacral space and proctectomy and Brooke's ileostomy was undertaken at 3 years after the primary operation. In addition, one ileorectostomy was converted to Brooke's ileostomy because of ileal necrosis and peritonitis one week after the primary operation. One patient had moderate dysplastic changes in rectal mucosa, which was primarily treated with local excision. Afterwards, this same patient suffered from lymphoma of the terminal ileum (PTLD, post-transplantation lymphoprolif-erative disease), and ileal resection, proctectomy and Brooke's ileostomy were undertaken.
In all, seven of twenty (35 %) IRAs were lost for operation related complications or proctitis (Table 2) . Cumulative success rate of ileorectal anastomosis, calculated with Kaplan Meier method, was 84 percent at 5 years, 69 percent at 10 years and 56 percent at 20 years (Table 3 , Fig. 1 ).
DISCUSSION
At our hospital, indications for ileorectal anastomosis in ulcerative colitis have always been strict. Thus, the number of patients in this analysis is small. The 5-year cumulative success rate (84 %) was same as reported by Pastore and his co-workers in series of 48 patients (8). Elton and co-workers reported 88 % success in their 18 patients, but the follow-up in that study was shorter (9). Ten year cumulative success (69 %) in our patient group was somewhat higher than reported by Leijonmarck (51 %) in 1990 (10) . Even smaller proctectomy rate has been reported in one study (10) . It is worth noting that IPAA was performed in only one of seven cases with failed IRA. This reflects partly the selected nature of our patient series (high-risk group). Immediate operative complications were rare, which speaks for the safeness of this procedure. The most common reason for proctectomy was recurrent inflammation in retained rectum and diarrhea following it, as also reported by others (8-9, 11). This occurred even if the selected patients had not had inflammatory changes in rectal mucosa before the operation. On the other hand, in Sweden it has been suggested that modern, active medical therapy minimizes the risk of proctitis and possibly also the cancer risk after IRA. The validity of this statement remains to be proven in long-term prospective followup studies.
In the literature, the overall risk of cancer developing is estimated to be around 4% (12) and the highest cancer rate (5.9 %) has been reported in Aylett's series of 374 unselected patients (13) . The cancer rate depends on the duration of follow-up, and a cumulative risk up to 17 % after 27 years of primary anastomosis (14) has been observed. In our series, where patients had been chosen for IRA according to strict indications, no rectal cancers were found in postoperative follow-up. One patient had moderate rectal dysplasia, which was treated locally. No cancers were found in two other studies with selected patients either (10, 15) . Even if postoperative rectal endoscopies are mandatory, it is relieving to know that in carefully selected, and often elderly, patients, cancer risk within ten years time sequence is minimal. In cases with advanced cancer the need for follow-up is naturally relative.
When compared with our previously reported results of Kock continent ileostomy and IPAA (6-7), the results with IRA are worse. We have 93 % and 96 % 5-year success and 86 % and 93 % 10-year success with continent ileostomy and IPAA, respectively. The failures of IRA occurred evenly during the first 10 years, whereas most failures with IPAA happen during the first five years. With Kock continent ileostomy, failures occurred also after ten years. However, when we think, that the patients selected for IRA procedure (after the year 1985) were not suitable for Kock continent ileostomy or IPAA because of operative risks, we consider our results with IRA satisfactory. In conclusion, IRA is worthy of consideration for high-risk patients, for whom ileoanal pouch is not feasible, because of low rate of severe complications associated with it. In the future, we are planning to continue keeping IPAA as the first line procedure in UC choosing IRA for selected high-risk or older patients. Also some patients, having colitis-associated stage IV carcinoma in colon, seem to benefit from IRA.
